Sign in with Google
bullish
Biogen Exercises Samsung Bioepis Call Option - Summary & Implications
309 Views29 Jun 2018 23:59
Samsung Biologics Co., Ltd (207940 KS) said in a regulatory filing that Biogen Inc (BIIB US) exercised Bioepis call option.
Link of this...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »- Tam Jai (2217 HK): Toridoll (3397 JP)'s Excellent Offer. Still.
- STTF Index Rebalance: Keppel DC REIT Replaces Jardine Cycle & Carriage
- Great Eastern (GE SP): OCBC Bumps Terms - $30.15/Share Exit Offer
- Event-Driven Optionality in ProSieben: Playing the Floor, Targeting the Upside
- Top 30 Best Performing Stocks in KOSPI in Past Week and Surging Price of Samsung Life Insurance
Top Unpaywalled Insights
More »- [IO Technicals 2025/23] Bearish Momentum Persists
- VEON US: Pakistan Towers Sale Frees Capital for Digital Growth in Core Market Ahead of Ukraine IPO
- Advanced Look: Navigating the New Macro Landscape Through Quantitative Alpha Generation Strategies
- [IO Technicals 2025/22] Bearish Momentum Strengthens
- Texas Power Play: Grid Sovereignty, Bitcoin, and the Future of AI
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Samsung Biologics Contract Manufacturing Deal with Moderna for COVID-19 Vaccines: Key Takeaways14 May 2021
- Samsung Biologics CMO Deal Noise & Samsung C&T Synthetic Subsidiary Stub Trade12 May 2021
- Samsung BioLogics (207940 KS): Korea FSC Ruling Summary & Clarifications12 Jul 2018
- Biogen Exercises Samsung Bioepis Call Option - Summary & Implications29 Jun 2018
- FSS Vs. Samsung BioLogics - Latest Situation Update09 May 2018
- Samsung BioLogics - Market Sentiment Assessment05 May 2018
x